Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
Herbert L DuvivierMichael RothePam K MangatElizabeth Garrett-MayerEugene R AhnTareq Al BaghdadiAjjai S AlvaStephanie A DublisTimothy L CannonCarmen J CalfaRui LiDeepti BehlVi K ChiuPhilip J GoldAlissa S MarrKathryn F MilehamSteven Francis PowellJordi Rodon AhnertRamya ThotaGina N GranthamAbigail GregoryDominique C HinshawSusan HalabiRichard L SchilskyPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Pembrolizumab demonstrated antitumor activity in pretreated patients with advanced cancers and HTMB.